Watkins and colleagues identified HORMAD1 as a gene whose expression was associated with allelic-imbalanced copy-number aberrations (AiCNA) in a cohort of 126 Triple Negative Breast Cancers (TNBC)32. The gene discussed is HORMAD1; the disease is triple-negative breast carcinoma.